The proposed two-phase generative–evolutionary framework provides a generalizable approach for balancing functional optimization and distributional realism and can be applied to peptide discovery and data augmentation in imbalanced biological datasets thereby generating high confidence peptides for wet lab validation.
Abstract
Recent advances in artificial intelligence have accelerated the discovery of bioactive peptides by enabling computational exploration of the vast peptide sequence space. However, existing peptide generation approaches generally rely on either distribution-learning models, which generate biologically realistic sequences but do not consistently optimize functional activity, or optimization-based methods, which maximize prediction confidence while often deviating from the underlying distribution of experimentally validated peptides. To address this limitation, a two-phase generative–evolutionary framework is proposed that integrates distribution learning with evolutionary optimization. In the first phase, Variational Autoencoders (VAE), Autoregressive Transformers (ART), and Token Diffusion Transformers (TDT) are used to generate biologically plausible seed peptides. In the second phase, these peptides were used as initial seed for Hill Climbing optimization procedure that iteratively improves fitness function score. The proposed two-phase framework was evaluated using a dataset of experimentally validated IL-2-inducing peptides. Evaluation using independent IL-2 prediction models showed that Autoregressive Transformer combined with Hill Climbing achieved the best overall performance, achieving the mean IL-2 induction confidence score of 0.96 while reducing KL divergence from 2.26 for standalone Hill Climbing to 0.75. A case study on an independent IL-13 inducing peptide dataset showed similar trends, with ART initialized Hill Climbing achieving the mean IL-13 induction score of 0.99 while reducing KL divergence from 1.76 to 0.59. Overall, the framework provides a generalizable approach for balancing functional optimization and distributional realism and can be applied to peptide discovery and data augmentation in imbalanced biological datasets thereby generating high confidence peptides for wet lab validation. Highlights Proposed a two-phase framework for bioactive peptide generation with potential to address class imbalance in peptide classification tasks. Performed a systematic comparison of distribution-learning and optimization-based approaches for peptide generation. Combined distribution-learning models for sequence generation with optimization algorithms for improving peptide functional properties. Demonstrated the applicability of the proposed framework across multiple bioactive peptide datasets.
This review systematically examines the key methodological innovations, including peptide representation learning, multi-modal fusion strategies, multi-label learning paradigms, and emerging predictive frameworks empowered by deep neural architectures and ProtLM-based embeddings, and summarizes the practical applicatio...
A snapshot of AI-driven technologies for AMP design is provided and two modes of AI-driven technologies for AMP design are surveyed, one concentrated on identifying whether current data possess antimicrobial activity and the other on generating AMP candidates with potential therapeutic properties (generation-oriented).
Yong-Qiang Liu, Jie Hu, Ning Zhang et al.· Synthetic and Systems Biotec...· 0 citations
HighMorph is presented, an interaction-guided framework that combines protein–protein interaction information with artificial intelligence for rational cyclic peptide design and provides insights for developing therapeutics targeting challenging protein interfaces.
M. Lan, Cheng-Yun Zhang, Wentong Wang et al.· Journal of Medicinal Chemist...· 0 citations
A strategic roadmap for seamlessly integrating generative AI with physics-based validation with physics-based validation is provided, thereby accelerating the transition of computationally designed peptides from in silico blueprints to viable clinical candidates.
Wenjing Hu, Yuantao Sun, Ting Li et al.· The Innovation Drug Discover...· 2 citations
ScrambleBench provides a holistic medicinal chemistry-oriented framework that identifies methodological strengths, limitations, and opportunities for future model development and highlights the importance of evaluating chemical diversity explicitly and using the recently proposed metrics such as Hamiltonian Diversity (...
Veincent Yap, Pan Xu, Frankie S. Mak et al.· Journal of Cheminformatics· 0 citations
A new concept termed DeepPepQSAR that integrates deep learning into traditional PepQSAR is proposed to quantitatively model, predict, and interpret the BAP universe in an all-in-one manner for artificial intelligence (AI)-driven big-data BAP discovery.
P. Zhou, Kexin Li, Yu-Lu Gan et al.· Molecular diversity· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.